Refractory palmoplantar pustulosis succesfully treated with apremilast

被引:7
|
作者
de Lome, Raquel Carrascosa [1 ]
Montero, Elena Conde [1 ]
Dobao, Pablo de la Cueva [1 ]
机构
[1] Hosp Univ Infanta Leonor, Dermatol Dept, Ave Gran Via Este 80, Madrid 28031, Spain
关键词
inflammatory disorders; psoriasis; therapy-systemic; PHASE-III; INHIBITOR; PSORIASIS; EFFICACY; MODERATE;
D O I
10.1111/dth.13230
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Palmoplantar pustulosis is a chronic inflammatory disease which characterized by a eruption of sterile pustules on the palms and soles. Apremilast is an oral phosphodiesterase-4 inhibitor which is approved for the treatment of chronic plaque psoriasis and psoriatic arthritis. However, no clinical trial has been performed to confirm the efficacy of apremilast for palmoplantar pustulosis yet. Moreover, there are very few cases of this disease treated with apremilast. Herein, we describe a case of a refractory palmoplantar pustulosis succesfully treated with apremilast.
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Successful treatment of refractory palmoplantar pustulosis with apremilast
    Haebich, G.
    Kalavala, M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (04) : 471 - 473
  • [2] Three cases of palmoplantar pustulosis successfully treated with apremilast
    Eto, Ayaka
    Nakao, Masayoshi
    Furue, Masutaka
    JOURNAL OF DERMATOLOGY, 2019, 46 (01): : E29 - E30
  • [3] Comparative analysis of apremilast in palmoplantar psoriasis and palmoplantar pustulosis
    Spencer, Riley
    Elhage, Kareem
    Jin, Joy
    Davis, Mitchell
    Hakimi, Marwa
    Bhutani-Jacques, Tina
    Liao, Wilson
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB138 - AB138
  • [4] Successful Treatment of Palmoplantar Pustulosis With Apremilast
    Dorgham, Noelle, III
    Crasto, David
    Skopit, Stanley
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (11) : 1255 - 1256
  • [5] Apremilast in the treatment of palmoplantar pustulosis A case series
    Frischhut, Nina
    Ratzinger, Gudrun
    HAUTARZT, 2021, 72 (03): : 252 - 256
  • [6] Apremilast in treatment of palmoplantar pustulosis - a case series
    Soufila, K. T.
    Thakur, Vishal
    Narang, Tarun
    Dogra, Sunil
    Handa, Sanjeev
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (06) : E247 - E248
  • [7] Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
    Riley K. Spencer
    Kareem G. Elhage
    Joy Q. Jin
    Mitchell S. Davis
    Marwa Hakimi
    Tina Bhutani
    Wilson Liao
    Dermatology and Therapy, 2023, 13 : 437 - 451
  • [8] Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
    Marovt, Maruska
    Marko, Pij B.
    SAGE OPEN MEDICAL CASE REPORTS, 2021, 9
  • [9] Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
    Spencer, Riley K. K.
    Elhage, Kareem G. G.
    Jin, Joy Q. Q.
    Davis, Mitchell S. S.
    Hakimi, Marwa
    Bhutani, Tina
    Liao, Wilson
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 437 - 451
  • [10] Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
    Xu, Qingqing
    Wang, Xiaochen
    Yang, Anbo
    Wei, Guo
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 5165 - 5172